|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/454 | |||
| C07K 16/28 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2476438 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10815436.0 |
| Date of filing the European patent application | 2010-09-09 | |
| (97) | Date of publication of the European application | 2012-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2010/065566 |
| Date | 2010-09-09 |
| (87) | Number | WO 2011/030841 |
| Date | 2011-03-17 |
| (30) | Number | Date | Country code |
| 2009209218 | 2009-09-10 | JP | |
| 241558 P | 2009-09-11 | US |
| (72) |
ISHII, Toshihiko, JP
ASANO, Miyoko, JP
|
| (73) |
Kyowa Hakko Kirin Co., Ltd.,
1-6-1, Ohtemachi Chiyoda-ku, Tokyo 100-8185,
JP
|
| (54) | MEDICAMENT INCLUDING ANTIBODY COMPOSITION SPECIFICALLY BOUND TO HUMAN CC CHEMOKINE RECEPTOR 4 (CCR4) |
| MEDICAMENT INCLUDING ANTIBODY COMPOSITION SPECIFICALLY BOUND TO HUMAN CC CHEMOKINE RECEPTOR 4 (CCR4) |